Albiglutide
CER-4-T2D
GSK · Phase n/r · Active, not recruiting · Enrollment 781430
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| SGLT-2i (Comparison 1) | n/r | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 1) | n/r | n/r | n/r | n/r | n/r |
| SGLT-2i (Comparison 2) | n/r | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 2) | n/r | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 3) | n/r | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 3) | n/r | n/r | n/r | n/r | n/r |
| SGLT-2i (Comparison 4) | n/r | n/r | n/r | n/r | n/r |
| SU (Comparison 4) | n/r | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 5) | n/r | n/r | n/r | n/r | n/r |
| SU (Comparison 5) | n/r | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 6) | n/r | n/r | n/r | n/r | n/r |
| SU (Comparison 6) | n/r | n/r | n/r | n/r | n/r |
| SGLT2i (Comparison 7) | n/r | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 7) | n/r | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 7) | n/r | n/r | n/r | n/r | n/r |
| SU (Comparison 7) | n/r | n/r | n/r | n/r | n/r |
| SGLT2i (Comparison 8) | n/r | n/r | n/r | n/r | n/r |
| GLP-1 RA (Comparison 8) | n/r | n/r | n/r | n/r | n/r |
| DPP-4i (Comparison 8) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.